
What Ultra-Processed Foods May Mean for Your Type 1 Diabetes Health
A new study of adults with Type 1 diabetes finds that higher intake of ultra-processed foods is linked to unhealthy cholesterol patterns and changes in gut bacteria. Understanding these connections may help inform dietary choices.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Adults with Type 1 diabetes who ate more ultra-processed foods had higher triglycerides and lower HDL cholesterol—markers of increased cardiovascular risk.
- Sugary and artificially sweetened drinks, plus certain ready-to-eat dishes, were particularly associated with higher triglycerides and worse blood sugar control in some participants.
- The gut microbiome composition differed based on how much ultra-processed food people consumed, suggesting these foods may affect the bacteria that live in our digestive system.
- This study shows associations between ultra-processed food intake and health markers, but does not prove that cutting back on these foods will improve outcomes.
The Study: Examining Food Choices and Health in Type 1 Diabetes
Researchers in Southern Italy wanted to understand how ultra-processed foods (UPFs)—foods that are heavily manufactured and typically contain added sugars, unhealthy fats, and additives—might affect the health of adults living with Type 1 diabetes. They enrolled 253 participants and looked at three key areas: what people ate, their blood sugar and cholesterol levels, and the composition of bacteria in their gut.
Participants completed a detailed food questionnaire, and researchers measured their lipid profiles, HbA1c (a marker of average blood sugar over three months), and continuous glucose monitoring data. A smaller group of 103 participants also had their gut microbiota analyzed using advanced genetic sequencing.
What the Findings Show About Cholesterol and Triglycerides
On average, ultra-processed foods made up about 15.5% of total food intake in this group. The researchers found that people who ate more ultra-processed foods tended to have higher triglycerides (a type of fat in the blood) and lower HDL cholesterol (often called 'good' cholesterol). Both of these patterns are associated with increased cardiovascular risk.
Certain types of ultra-processed foods showed stronger associations: sugary and artificially sweetened drinks were linked to higher triglycerides, while animal-based ultra-processed foods (like processed meats) were associated with lower HDL cholesterol. Ready-to-eat mixed dishes were linked to higher HbA1c in people using multiple daily insulin injections or traditional insulin pumps.
Changes in Gut Bacteria and What They May Mean
The composition of gut bacteria differed significantly between people who ate more ultra-processed foods versus those who ate fewer. The researchers identified specific bacterial pathways involved in metabolism that were associated with higher triglyceride levels, suggesting a biological link between what we eat, our gut bacteria, and our cholesterol patterns.
While these findings are intriguing, the meaning of these microbiome changes for long-term health is not yet fully understood. More research is needed to determine whether altering ultra-processed food intake could shift the microbiome in beneficial ways.
What This Means—And What It Doesn't
This study identifies associations between ultra-processed food intake and several health markers in people with Type 1 diabetes. It adds to existing evidence that diet composition matters for cardiovascular health and blood sugar management in this population.
It's important to note that this research shows correlation, not causation. The study does not prove that reducing ultra-processed foods will improve cholesterol levels, blood sugar control, or gut health—though these associations suggest it's worth exploring with your healthcare team. Individual responses to dietary changes vary, and any modifications to your eating plan should be made in consultation with your diabetes care provider or dietitian.
Evidence label
Source: Diabetes research and clinical practice. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowA New Material Design Aims to Keep Transplanted Insulin-Producing Cells AlivePubMed indexed literature
- Causes & What We KnowWhat Matters More for Heart Health in Type 1 Diabetes: Liver Fat or Body Composition?PubMed indexed literature
- Causes & What We KnowNew Study Examines Two Environmental Triggers in Type 1 DiabetesPubMed indexed literature
- Causes & What We KnowDoes Winter Bring More Cases of Diabetic Ketoacidosis? What New Research ShowsPubMed indexed literature
- Causes & What We KnowWhat Thiols Tell Us About Type 1 Diabetes Complications in ChildrenPubMed indexed literature
- Causes & What We KnowA Molecule Called miR-30d-5p Shows Promise in Supporting Beta Cell RecoveryPubMed indexed literature